Bio-Techne
William Blair Initiates Coverage of Bio-Techne With Outperform Rating
The investment bank emphasized Bio-Techne's position in multiple high-growth and attractive end markets, including cell and gene therapy, spatial biology, and liquid biopsy.
Sylvester Comprehensive Cancer Center Wins $2.5M NCI Grant to Develop Prostate Cancer Test
The team will work with collaborators at Bio-Techne's Exosome Diagnostics to develop its prostate cancer biomarker on a new platform.
The company said on Tuesday that its fiscal fourth quarter revenues rose 5 percent and full-year 2023 revenues climbed 3 percent.
In Brief This Week: Labcorp; T2 Biosystems; Thermo Fisher Scientific; Bio-Techne; More
News items for the week of July 10, 2023.
Top Five Articles on 360Dx Last Week: FDA CDx Pilot Program; CDC Training Program Launched; and More
Last week, readers were most interested in a story about a pilot program to help improve the performance of laboratory-developed companion diagnostics.
Feb 1, 2023
360Dx Top 30 Starts the Year up 1 Percent
Nov 1, 2022
Bio-Techne Fiscal Q1 Revenues Rise 5 Percent
Aug 4, 2022
Aug 4, 2022
Bio-Techne Q4 Revenues Climb 11 Percent
May 4, 2022